RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
  Bacteriology
  Virology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Microbiology Channel

subscribe to Microbiology newsletter
Latest Research : Microbiology

   EMAIL   |   PRINT
Bacteria can use a Sonar-like system to spot other cells

Dec 24, 2004 - 3:57:00 PM

 
[RxPG] For the first time, scientists have found that bacteria can use a Sonar-like system to spot other cells (either normal body cells or other bacteria) and target them for destruction. Reported in the December 24 issue of Science, this finding explains how some bacteria know when to produce a toxin that makes infection more severe. It may lead to the design of new toxin inhibitors. "Blocking or interfering with a bacterium's "detection" mechanism, should prevent toxin production and limit the severity of infection," says Michael Gilmore, PhD, lead author of the study, and currently director of research at the Schepens Eye Research Institute and professor of ophthalmology at Harvard Medical School.

Gilmore and his team have spent years studying the bacterium known as Enterococcus faecalis, one of the leading causes of hospital-acquired infections, to find new ways to treat them. These infections are frequently resistant to many, and sometimes all, antibiotics. Tens of thousands of deaths due to antibiotic resistant infection occur each year in the US, adding an estimated $ 4 Billion to health care costs. Scientist have known since 1934 that especially harmful strains of Enterococcus produce a toxin that destroys other cells, including human cells and even other types of bacteria. They also knew that this toxin was made only under some conditions. Until Gilmore's study, scientists were unable to explain how the Enterococcus knew when to make it.

In the Science study, Gilmore and his team found that this toxin is made whenever there is another cell type in the environment near the bacterium, such as a human blood cell. They discovered how these bacteria know when other cells are present, and respond accordingly.

In the laboratory, the team found that Enterococcus releases two substances into the environment. One substance sticks to foreign cells. The second substance reports back and tells the Enterococcus to make the toxin. If no cells are in the area, the first substance sticks to the second, preventing it from reporting back to the Enterococcus, and as a result, no toxin is made. According to Gilmore, "These bacteria are actively probing their environment for enemies or food. Based on whether or not they 'see' other cells, they make the toxin appropriately."

Gilmore says this discovery has several significant implications for the future. "This is a new mechanism that nature devised to 'see' the environment, and based on that information, respond accordingly. We may be able to learn from nature and adapt a similar strategy to help the aging population cope with loss of vision," says Gilmore.

"Secondly, this discovery will help us to develop new ways to treat infections that are resistant to antibiotics, making them less severe. Based on an understanding of how this toxin system works, we hope to develop toxin inhibitors," says Gilmore.

The third area of interest is currently science fiction, says Gilmore. "If bacteria can see cells in the environment, maybe we can tame these bacteria and engineer this system so that it can be used to see other things in the environment, such as minerals or possibly other disease-causing bacteria," says Gilmore.



Publication: December 24 issue of Science

Advertise in this space for $10 per month. Contact us today.


Related Microbiology News
Predatory bacteria attack in 'military-style' waves
The Strange Case of the Radiation-Resistant Bacteria
Evolution of typhoid bacteria
New Treatment Using Human Antibodies to Target Harmful Toxins May Protect Against C. Difficile
Guinea Pig Aerosol Challenge Presents New Model for Q Fever Research in Humans
Gut Bacteria Cospeciating with Plataspid stinkbug
How West Nile virus evades immune defenses
An infectious agent of deception, exposed through proteomics
Gram positive bacterial membrane mystery solved
E.Coli uses 'shock absorbers' to combat adverse conditions

Subscribe to Microbiology Newsletter

Enter your email address:


 Additional information about the news article
Other members of the research team included Drs. Phillip Coburn, University of Oklahoma Health Sciences Center, Christopher Pillar, Schepens Eye Research Institute and Harvard Medical School, Wolfgang Haas, University of Rochester, and Bradley D. Jett, Oklahoma Baptist University. Dr. Michael S. Gilmore is presently Charles L. Schepens Professor of Ophthalmology, Harvard Medical School, and Marie and DeWalt Ankeny Director and Acting CEO of the Schepens Eye Research Institute.

For a copy of the article titled, "Enterococcus faecalis Senses Target Cells and in Response Expresses Cytolysin" call AAAS Public Affairs Office at 1-202-326-6440 or email [email protected].

Schepens Eye Research Institute is an affiliate of Harvard Medical School and the largest independent eye research institute in the world.
 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)